Home » Genzyme Weighs Plan to Protect Shareholders
Genzyme Weighs Plan to Protect Shareholders
Top executives at Genzyme Corp. are weighing a plan that would give shareholders a bigger return if the company is sold and its new drug to treat multiple sclerosis later proves highly successful.
boston
boston
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May